BRL 20627: promotes gastric emptying [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 127317 |
| CHEMBL ID | 68649 |
| SCHEMBL ID | 15532024 |
| MeSH ID | M0136883 |
| Synonym |
|---|
| n-[(2s,6r,9ar)-6-methyl-2,3,4,6,7,8,9,9a-octahydro-1h-quinolizin-2-yl]-4-amino-5-chloro-2-hydroxy-benzamide |
| bmy-27709 |
| benzamide, 4-amino-n-[(2s,6r,9ar)-octahydro-6-methyl-2h-quinolizin-2-yl]-5-chloro-2-hydroxy- |
| brl 20627 |
| CHEMBL68649 |
| 99390-76-8 |
| n-[(2s,6r,9ar)-6-methyl-2,3,4,6,7,8,9,9a-octahydro-1h-quinolizin-2-yl]-4-amino-5-chloro-2-hydroxybenzamide |
| benzamide, 4-amino-5-chloro-2-hydroxy-n-(octahydro-6-methyl-2h-quinolizin-2-yl)-, (2alpha,6beta,9aalpha)-(+-)- |
| 4-amino-5-chloro-2-hydroxy-n-(octahydro-6-methyl-2h-quinolizin-2yl)benzamide |
| SCHEMBL15532024 |
| DTXSID70912727 |
| 4-amino-5-chloro-2-hydroxy-n-(6-methyloctahydro-2h-quinolizin-2-yl)benzene-1-carboximidic acid |
| 4-amino-5-chloro-2-hydroxy-n-((2s,6r,9ar)-6-methyloctahydro-2h-quinolizin-2-yl)benzamide |
| AKOS040748029 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID226667 | Compound tested for inhibition of hemolysis | 2001 | Bioorganic & medicinal chemistry letters, Sep-03, Volume: 11, Issue:17 | An approach to the identification of potent inhibitors of influenza virus fusion using parallel synthesis methodology. |
| AID92331 | Cytotoxicity against A/WSN/33 strain (an H1N1 subtype) influenza virus in the plaque reduction assay | 1999 | Bioorganic & medicinal chemistry letters, Aug-02, Volume: 9, Issue:15 | Novel quinolizidine salicylamide influenza fusion inhibitors. |
| AID92460 | Compound tested for inhibition of influenza virus infectivity in cell culture determined by plaque reduction assay | 2001 | Bioorganic & medicinal chemistry letters, Sep-03, Volume: 11, Issue:17 | An approach to the identification of potent inhibitors of influenza virus fusion using parallel synthesis methodology. |
| AID92458 | Cytotoxicity of compound was measured against Influenza virus | 2001 | Bioorganic & medicinal chemistry letters, Sep-03, Volume: 11, Issue:17 | An approach to the identification of potent inhibitors of influenza virus fusion using parallel synthesis methodology. |
| AID105607 | Inhibitory activity against A/WSN/33 strain (an H1N1 subtype) influenza virus was measured by cell protection assay in MDBK cells | 1999 | Bioorganic & medicinal chemistry letters, Aug-02, Volume: 9, Issue:15 | Novel quinolizidine salicylamide influenza fusion inhibitors. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.14) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 2 (40.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 3 (60.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||